(Q44125042)

30 November 2017

Effects of L-DOPA on pharmacological parkinsonism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5335155

3 May 2023

1 reference

1

A Bruno

1 reference

30 November 2017

2

S C Bruno

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 January 1966

1 reference

full work available at URL

30 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1966.tb01931.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1966.tb01931.x/fullpdf

3 May 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

Acta Psychiatrica Scandinavica

3 May 2023

published in

1 reference

30 November 2017

42

1 reference

30 November 2017

264-271

1 reference

30 November 2017

3

1 reference

On the distribution in brain of monoamines and of enzymes responsible for their formation.

30 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1966.TB01931.X

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1966.TB01931.X

Chemical and physiological changes produced by arterial infusion of dihydroxyphenylalanine into one cerebral hemisphere of the cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1966.TB01931.X

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1966.TB01931.X

Interference of chlorpromazine with the metabolism of aromatic amino-acids in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1966.TB01931.X

[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis]

21 January 2018

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM

3 May 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

The effect of haloperidol on the urinary excretion of dopamine, homovanillic and vanilmandelic acids in schizophrenics

3 May 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

3 May 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

[On the effects of L-dopa in man and their modification by reserpine, chlorpromazine, iproniazid and vitamin B6]

3 May 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

Dihydroxyphenylalanine in extrapyramidal disease.

3 May 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

Journal of Pharmacology and Experimental Therapeutics

3 May 2023

18

233

18

Gey K. F.

1961

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

Journal of Pharmacology and Experimental Therapeutics

3 May 2023

20

245

337

Gey K. F.

1964

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1966.TB01931.X

3 May 2023

Identifiers

1 reference

30 November 2017

1 reference